登录新浪财经APP 搜索【信披】查看更多考评等级 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示: ■ 一、信息披露义务人及一致行动人基本信息 （一）信息披露义务人基本信息 2、本次股东权益变动不涉及信息披露义务人披露权益变动报告书； 3、本次权益变动为持股5%以上非第一大股东减持，不会导致公司控股股东、实际控制人发生变化，不 会对公司治理结构及持续经营产生重大影响。 ■ （二）一致行动人基本信息 信息披露义务人上海翱鹏企业管理中心（有限合伙）不存在一致行动人。 二、权益变动触及1%刻度的基本情况 上海益诺思生物技术股份有限公司（以下简称"公司"）于2026年1月16日收到股东上海翱鹏企业管理中 心（有限合伙）（以下简称"翱鹏合伙"）出具的告知函，翱鹏合伙自2026年1月14日～2026年1月16日期 间通过集中竞价交易方式减持其所持有的公司股份512,000股，占公司总股本的0.36%，减持后持有公司 股份16,900,396股，持股比例为11.99%，权益变动触及《上市公司收购管理办法》《证券期货法律适用 ...

格隆汇1月16日丨益诺思(688710.SH)公布，于2026年1月16日收到股东上海翱鹏企业管理中心(有限合伙) (以下简称"翱鹏合伙")出具的告知函，翱鹏合伙自2026年1月14日～2026年1月16日期间通过集中竞价交 易方式减持其所持有的公司股份512,000股，占公司总股本的0.36%，减持后持有公司股份16,900,396 股，持股比例为11.99%。 ...

证券代码：688710 证券简称：益诺思 公告编号：2026-003 上海益诺思生物技术股份有限公司 关于股东权益变动触及1%刻度的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: | 权益变动方向 | 比例增加□ | | 比例减少√ | | --- | --- | --- | --- | | 权益变动前合计比例 | 12.35% | | | | 权益变动后合计比例 | 11.99% | | | | 本次变动是否违反已作出的承诺、意向、计划 | 是□ | 否√ | | | 是否触发强制要约收购义务 | 是□ | 否√ | | 一、信息披露义务人及一致行动人基本信息 （一）信息披露义务人基本信息 信息披露义务人上海翱鹏企业管理中心（有限合伙）不存在一致行动人。 二、权益变动触及 1%刻度的基本情况 上海益诺思生物技术股份有限公司（以下简称"公司"）于 2026 年 1 月 16 日收到股东上海翱鹏企业管理中心（有限合伙）（以下简称"翱鹏合伙"）出具 的告知函，翱鹏合伙自 2026 年 1 月 14 ...

格隆汇1月16日｜上海益诺思公告称，2026年1月14 - 16日，股东上海翱鹏企业管理中心（有限合伙）通 过集中竞价减持51.2万股，占总股本0.36%。减持后其持股降至1690.0396万股，比例由12.35%降至 11.99%，触及1%的整数倍标准。本次减持是履行已披露计划，尚未实施完毕。该变动不会使公司控股 股东、实控人变更，也不涉及披露权益变动报告书。 ...

汇添富医药保健混合（470006）成立日期2010年9月21日，最新规模24.86亿。今年以来收益10.43%，同 类排名654/8838；近一年收益41.9%，同类排名3211/8089；成立以来收益171.57%。 汇添富医药保健混合（470006）基金经理为郑磊。 截至发稿，郑磊累计任职时间11年32天，现任基金资产总规模80.93亿元，任职期间最佳基金回报 58.54%， 任职期间最差基金回报-27.52%。 1月14日，益诺思跌5.01%，截至发稿，报66.00元/股，成交1.98亿元，换手率3.17%，总市值93.05亿 元。 资料显示，上海益诺思生物技术股份有限公司位于中国(上海)自由贸易试验区郭守敬路199号106室，成 立日期2010年5月12日，上市日期2024年9月3日，公司主营业务涉及专业提供生物医药非临床研究服务 为主的综合研发服务(CRO)。主营业务收入构成为：非临床96.31%，临床3.42%，其他0.27%。 从益诺思十大流通股东角度 数据显示，汇添富基金旗下1只基金位居益诺思十大流通股东。汇添富医药保健混合（470006）三季度 新进十大流通股东，持有股数112.15万股，占 ...

Group 1 - The core point of the news is that Yinosh experienced a decline of 5.01% in its stock price, closing at 66.00 CNY per share, with a trading volume of 198 million CNY and a turnover rate of 3.17%, resulting in a total market capitalization of 9.305 billion CNY [1] - Yinosh Biotechnology Co., Ltd. is located in the China (Shanghai) Pilot Free Trade Zone and was established on May 12, 2010. The company specializes in providing comprehensive research and development services (CRO) primarily focused on non-clinical research services [1] - The revenue composition of Yinosh is heavily weighted towards non-clinical services, accounting for 96.31%, while clinical services contribute 3.42% and other services make up 0.27% [1] Group 2 - From the perspective of Yinosh's top ten circulating shareholders, Huaxia Fund has a fund that ranks among the top shareholders, specifically Huaxia Stable Growth Mixed Fund (005450), which entered the top ten in the third quarter with 930,500 shares, representing 1.03% of the circulating shares [2] - The estimated floating loss for Huaxia Stable Growth Mixed Fund today is approximately 3.2381 million CNY [2] - The fund was established on January 17, 2018, with a current scale of 1.09 billion CNY, achieving a year-to-date return of 12.99% and a one-year return of 29.73% [2] Group 3 - The fund manager of Huaxia Stable Growth Mixed Fund is Luo Haoliang, who has been in the position for 7 years and 98 days, overseeing a total asset scale of 1.09 billion CNY [3] - During his tenure, the best fund return achieved was 41.66%, while the worst return was -21.48% [3] Group 4 - Huaxia Stable Growth Mixed Fund holds Yinosh as a significant investment, with 930,500 shares representing 4% of the fund's net value, making it the seventh-largest holding [4] - The estimated floating loss for the fund regarding its investment in Yinosh is approximately 3.2381 million CNY [4]

Market Overview - The A-share market experienced a collective pullback on January 13, with the Shanghai Composite Index ending a 17-day winning streak, closing down by 0.64% [1] - The Shenzhen Component Index fell by 1.37%, and the ChiNext Index decreased by 1.96%, with a total trading volume of 3.7 trillion yuan, setting a new historical record [1][2] Sector Performance - Multiple sectors faced significant declines, particularly in commercial aerospace and satellite internet, with nearly 100 stocks dropping over 8% [4] - The large aircraft and military sectors also saw declines, with stocks like Zhongtian Rocket and Leike Defense hitting the daily limit down [4] - The controlled nuclear fusion sector experienced a downturn, with Wangzi New Materials hitting the daily limit down [4] - The communication equipment sector fell, with stocks like Changjiang Communication hitting the daily limit down [4] Stock Movements - Over 1,600 stocks rose, with more than 70 stocks hitting the daily limit up [4] - The commercial aerospace concept stocks suffered heavy losses, with over 60 stocks hitting the daily limit down or dropping more than 10% [4] - Specific stocks such as Aerospace Electronics and Beidou Star Communication saw significant declines, with many military stocks also hitting the daily limit down [6] Investment Insights - The market sentiment has shifted from hesitation to active allocation, driven by a consensus on the current market rally [10] - Investors are advised to avoid speculative risks in popular sectors, particularly in commercial aerospace, and to focus on policy and industry resonance themes such as technological innovation and high-end manufacturing [11] - Key investment areas include sectors with performance support, such as overseas computing power, storage, consumer electronics, and wind energy storage, which still have room for low-cost allocation [10][11]

Market Overview - A-shares experienced a collective pullback on January 13, with the Shanghai Composite Index ending a 17-day winning streak, closing down 0.64% [1] - The total trading volume in the Shanghai and Shenzhen markets reached a historical high of 3.7 trillion [1] Sector Performance - Significant declines were observed in various sectors, including commercial aerospace, satellite internet, and military industries, with many stocks dropping over 8% [3] - The large aircraft and military sectors also faced downturns, with several stocks hitting the daily limit down [3] - The commercial aerospace index fell by 6.15%, with a net outflow of 230.78 billion [4] Individual Stock Movements - Over 1,600 stocks rose, with more than 70 stocks hitting the daily limit up, while the commercial aerospace sector saw over 60 stocks limit down or drop more than 10% [3] - Specific stocks such as Aerospace Electronics and Beidou Star Communication experienced significant declines, with many stocks in the sector down by nearly 10% [7] Investment Insights - Analysts suggest that the current market sentiment may indicate a nearing peak, with potential for further structural upward trends despite short-term volatility [12] - Key investment strategies include avoiding speculative risks in popular sectors, focusing on policy-driven industries, and maintaining diversified portfolios to balance risk and return [14] - The emphasis is on sectors with strong earnings growth and valuation alignment, particularly in technology manufacturing and innovative healthcare [14]

两融数据显示，该股最新(1月9日)两融余额为2.32亿元，其中，融资余额为2.32亿元，近10日增加 1861.92万元，环比增长8.74%。 证券时报·数据宝统计显示，泓博医药所属的医药生物行业，目前整体涨幅为0.12%，行业内，目前股价 上涨的有198只，涨停的有迪安诊断、美年健康等3只。股价下跌的有276只，跌幅居前的有海思科、三 生国健、益诺思等，跌幅分别为6.41%、4.22%、4.20%。 泓博医药股价创出历史新高，截至9:43，该股上涨9.48%，股价报45.15元，成交量1164.15万股，成交金 额5.20亿元，换手率9.27%，该股最新A股总市值达63.02亿元，该股A股流通市值56.72亿元。 公司发布的三季报数据显示，前三季度公司共实现营业收入5.14亿元，同比增长31.43%，实现净利润 3474.96万元，同比增长127.96%，基本每股收益为0.2489元，加权平均净资产收益率3.30%。 ...

泓博医药股价创出历史新高，截至9:43，该股上涨9.48%，股价报45.15元，成交量1164.15万股，成交金 额5.20亿元，换手率9.27%，该股最新A股总市值达63.02亿元，该股A股流通市值56.72亿元。 证券时报·数据宝统计显示，泓博医药所属的医药生物行业，目前整体涨幅为0.12%，行业内，目前股价 上涨的有198只，涨停的有迪安诊断、美年健康等3只。股价下跌的有276只，跌幅居前的有海思科、三 生国健、益诺思等，跌幅分别为6.41%、4.22%、4.20%。 两融数据显示，该股最新（1月9日）两融余额为2.32亿元，其中，融资余额为2.32亿元，近10日增加 1861.92万元，环比增长8.74%。 公司发布的三季报数据显示，前三季度公司共实现营业收入5.14亿元，同比增长31.43%，实现净利润 3474.96万元，同比增长127.96%，基本每股收益为0.2489元，加权平均净资产收益率3.30%。（数据 宝） （文章来源：证券时报网） ...